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The complex multiprotein systems for the assembly of protein-
bound iron–sulfur (Fe–S) clusters are well defined in Gram-
negative model organisms. However, little is known about
Fe–S cluster biogenesis in other bacterial species. The ISC
(iron–sulfur cluster) operon of Mycobacterium tuberculosis
lacks several genes known to be essential for the function
of this system in other organisms. However, the cysteine
desulfurase IscSMtb (Rv number Rv3025c; Mtb denotes
M. tuberculosis) is conserved in this important pathogen.
The present study demonstrates that deleting iscSMtb renders the
cells microaerophilic and hypersensitive to oxidative stress.
Moreover, the iscSMtb mutant shows impaired Fe–S cluster-
dependent enzyme activity, clearly indicating that IscSMtb is
associated with Fe–S cluster assembly. An extensive interaction
network of IscSMtb with Fe–S proteins was identified, suggesting
a novel mechanism of sulfur transfer by direct interaction
with apoproteins. Interestingly, the highly homologous IscS of
Escherichia coli failed to complement the iscSMtb mutant and
showed a less diverse protein-interaction profile. To identify a
structural basis for these observations we determined the crystal
structure of IscSMtb, which mirrors adaptations made in response
to an ISC operon devoid of IscU-like Fe–S cluster scaffold
proteins. We conclude that in M. tuberculosis IscS has been
redesigned during evolution to compensate for the deletion of
large parts of the ISC operon.
Key words: iron–sulfur cluster, IscS, IscU, protein–protein
interaction, tuberculosis.
INTRODUCTION
Iron–sulfur (Fe–S) proteins and sulfur-containing cofactors are
ubiquitous in all kingdoms of life and participate in a plethora
of fundamental processes of biosynthetic pathways [1–4]. Fe–
S proteins are involved in redox systems, central metabolism,
respiration, gene regulation, RNA modification, and DNA
repair and replication. In humans, insufficiency in Fe–S cluster
biogenesis leads to some forms of sideroblastic anaemia as well as
Friedreich’s ataxia, a degenerative disease of the nervous system
[1].
To understand the mechanism by which these fragile clusters
are built, maintained and repaired has been of major interest
to the research community over the past two decades [2,3].
Owing to the multitude of Fe–S proteins (>150 predicted
proteins in Escherichia coli), their biosynthetic machineries have
a major effect on most essential metabolic pathways. Knowledge
of the individual differences in Fe–S cluster biogenesis of
different bacterial species may provide tools to better understand
evolutionary adaptations made in response to changing habitats
and strategies to combat bacterial pathogens.
To date, our knowledge of bacterial Fe–S cluster assembly
mechanisms is based primarily on investigations made in Gram-
negative bacteria. E. coli uses two multiprotein systems, ISC
(iron–sulfur cluster) and SUF (sulfur metabolism), to assemble
and deliver Fe–S clusters. The SUF system is active only under
conditions of oxidative stress or iron limitation, whereas the ISC
system is believed to be the housekeeping system that serves
most Fe–S proteins and enzymes using sulfur as their cofactor
[5,6]. Both systems function as complex machineries in which
up to eight individual proteins encoded by the iscRSUA-hscBA-
fdx operon (Figure 1) or the sufABCDSE operon participate
in a multistep process which delivers [2Fe–2S] and [4Fe–4S]
clusters to effector apoproteins. The central components of both
systems are cysteine desulfurases (IscS and SufS). These PLP
(pyridoxal 5′-phosphate)-dependent enzymes convert L-cysteine
into L-alanine leading to the release of a sulfur atom that forms a
persulfide on a cysteine residue of the enzyme [7,8]. In the case
of E. coli IscS, sulfur is transferred to the apo-form of the Fe–S
scaffold protein IscU by protein–protein interaction leading to the
formation of a [2Fe–2S] cluster in the presence of iron. Once two
[2Fe–2S] clusters have been generated on an IscU dimer, an [4Fe–
4S] cluster can be formed and transferred to Fe–S effector proteins
or the A-type carrier protein IscA. This protein is believed to have
a Fe–S cluster-delivery role. Release of IscU-bound Fe–S clusters
involves the ATP-hydrolysing activity of the co-chaperones HscA
and HscB [2]. The products of the stress-induced SUF operon are
similar to those of the ISC-operon. They include a scaffold protein
(SufB), an A-type carrier (SufA) and probably an ATPase (SufC)
triggering the release of Fe–S clusters from SufB [2,3].
The considerable amount of knowledge available concerning
Fe–S cluster biogenesis in Gram-negative bacteria is primarily
based on observations made in ISC-knockout mutants. The phen-
otypes of these mutant strains clearly demonstrate the importance
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Co-ordinates and structure factors for Mycobacterium tuberculosis IscS have been deposited in the PDB under accession code 4ISY.
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Figure 1 Comparison of ISC operons from different bacterial species
Genes involved in Fe–S cluster assembly are displayed in dark grey. The E. coli genome contains the full iscRSUA-hscBA-fdx operon which is found in most Gram-negative bacteria and serves as
a prototype for scaffold-based Fe–S-cluster assembly through IscA/U after liberation of sulfur from L-cysteine by the cysteine desulfurase IscS. In low-GC-content Gram-positive bacteria, such as
C. difficile, several assembly genes are missing. The non-Fe–S trmU gene, which is required for 2-thio-modification of some tRNAs, is the last gene of the operon. A very drastic change occurs in
M. tuberculosis and most actinomycetes where the operon is composed of the iscS and trmU genes only. All Fe–S scaffold proteins, as well as the regulatory protein IscR, are missing, which initially
led to the assumption that mycobacterial IscS is not involved in Fe–S-cluster assembly [13]. Through complementation studies performed on the iscS strain generated in the present study, the
presence of a putative promoter could be confirmed between Rv3026c and iscS.
of this operon under Fe–S cluster-damaging conditions. E. coli
strains with defects in Fe–S cluster biogenesis are hypersensitive
to H2O2 since Fe–S clusters are perturbed by stress conditions
such as oxidative stress [8,9]. Furthermore, the deletion of iscS in
E. coli leads to distinct alterations of growth rate under changing
oxygen tensions and impaired activity of Fe–S cluster-dependent
enzymes such as Acn (aconitase) [8]. These mutants were also
used to show that IscS has been highly conserved during evolution,
which facilitated heterologous complementation studies using
IscS copies of different organisms [9–12]. It was thus shown
that the slow-growth phenotype of an E. coli iscS strain could
be rescued by overexpressing the yeast IscS homologue Nfs1
(NiFS-like 1). Furthermore, IscSEc (where EC denotes E. coli.)
complements the deleted Nfs1 gene in yeast when expressed with a
presequence that shuttles the protein to the mitochondrion [10,11].
The formation of Fe–S clusters and the role of cysteine
desulfurases in Gram-positive bacteria are less well understood.
We performed a genomic analysis revealing that most low-GC-
content Gram-positive bacteria, such as Clostridium difficile,
display a reduced ISC operon where genes such as iscA and
the chaperones hscA and hscB are missing (Figure 1). In the
actinomycete Mycobacterium tuberculosis, a Gram-positive
bacterium with a high GC content, the reduction of the ISC
operon is even more dramatic and only the gene coding for
the cysteine desulfurase IscS (IscSMtb, where Mtb denotes
M. tuberculosis; Rv number Rv3025c) is retained (Figure 1).
Since M. tuberculosis contains a SUF operon comparable with
those found in many other bacteria, it is not known whether
IscSMtb is also involved in Fe–S cluster generation in vivo
[13]. However, a conserved region around the active-site cysteine
residue clearly indicates that IscSMtb is a group I (IscS-like)
cysteine desulfurase [14]. Furthermore, it was shown previously
that affinity-purified IscSMtb is capable of reconstituting the
[4Fe–4S] cluster of WhiB3 in vitro [15,16]. WhiB3 belongs to a
family of regulatory Fe–S proteins present only in actinomycetes
and their bacteriophages [17–20].
The survival and spread of M. tuberculosis relies on the
successful adaptation to extremely variable environments ranging
from high oxygen tensions in the lung to hypoxic conditions in
the granuloma. In addition, this intracellular pathogen encounters
changing redox conditions inside and outside the macrophage.
These rapidly changing environments require fine-tuned Fe–S
cluster biogenesis and repair. Indirect evidence of a role for
IscSMtb in the oxidative stress response is given by microarray
data showing that iscS is up-regulated after exposure to nitric
oxide and H2O2 [21]. To better understand the role of IscS in
mycobacterial Fe–S cluster biogenesis we created a iscSMtb
mutant which showed a phenotype strongly associated with
impaired Fe–S cluster assembly. Since an IscU homologue
is missing in the mycobacterial ISC operon, we tested for
direct interaction of IscSMtb with mycobacterial Fe–S proteins.
Intriguingly, we were able to identify an extensive IscS–Fe–S
protein-interaction network. Repeating these assays with the well-
described IscSEc instead of IscSMtb led to markedly different
results. Finally, we provide structural data explaining the failure
of IscSMtb to interact with IscU and the evolutionary deletion of
this gene from the mycobacterial ISC operon.
We conclude that the mycobacterial IscS has a role in Fe–S
cluster assembly and in combating oxidative stress, although the
respective ISC operon does not imply such a role. In addition we
show that the mycobacterial protein differs from IscS homologues
found in eukaryotes and Gram-negative bacteria.
MATERIALS AND METHODS
Bacterial strains, culture conditions and cloning strategies
M. tuberculosis H37Rv was grown in 7H9 broth (Difco)
supplemented with 0.2% glycerol, Middlebrook ADC
(albumin/dextrose/catalase) enrichment and 0.05% Tween 80
or on solid Middlebrook 7H10 medium (Difco) supplemented
with OADC (oleic acid/ADC). For selection, hygromycin,
streptomycin and kanamycin were used at a concentrations
of 50 μg/ml, 25 μg/ml and 20 μg/ml respectively and sucrose
was used at a concentration of 5%. Microaerophilic growth
was performed using the GasPakTM pouch system from Becton
Dickinson (EZ Campy system) or by overlaying M. tuberculosis
colonies on 7H10 agar with 10 ml of top agar (7H9 medium
with 0.75% agar). H2O2 exposure was performed in 7H9
broth with 5 mM H2O2 for 3 h. E. coli BL21(DE3) cells were
used for expression of His6-tagged IscSMtb in LB medium
containing 50 μg/ml ampicillin. All cloning steps were performed
as described previously using the In-Fusion PCR Cloning
kit (Clontech) [17]. Site-directed mutagenesis was performed
c© The Authors Journal compilation c© 2014 Biochemical Society
The mycobacterial cysteine desulfurase IscS and Fe–S biogenesis 469
using the QuikChange II system (Agilent) according to the
manufacturer’s recommendations. For cytotoxicity assays, THP-
1 macrophages were grown in RPMI 1640 medium supplemented
with 10% (v/v) FBS and activated with 200 nM PMA for 48 h.
Cells were washed and infected with mycobacteria at an MOI
(multiplicity of infection) of 5. MRC-5 fibroblasts were grown
in MEM (minimal essential medium) supplemented with 10%
(v/v) FBS and seeded into 96-well plates at 20000 cells per well.
Cells were allowed to adhere and myocobacteria were added at
an MOI of 10. After 24 h, extracellular bacteria were removed
by washing with PBS and, after an additional 48 h of incubation
in growth medium at 37 ◦C under 5% CO2, 10% PrestoBlue®
(Invitrogen) was added and the reaction was incubated for 1 h
after measurement of fluorescence at 560/590 nm.
Allelic exchange and unmarked deletion of iscS
Details of the primers and plasmids used are shown in Sup-
plementary Tables S1 and S2 (http://www.biochemj.org/bj/459/
bj4590467add.htm). M. tuberculosis H37Rv cells were washed
three times in 10% (v/v) glycerol and transformed with
pGA44:iscS followed by selection on 7H10 agar containing strep-
tomycin. These clones were transformed with pJG:Rv3026/trmU,
and positive clones were selected on 7H10 agar containing
hygromyin and kanamycin. Clones containing both plasmids
were plated on 7H10 agar with streptomycin and sucrose. The
deletion of trmU (tRNA 5-methylaminomethyl-2-thiouridylate
methyltransferase) was performed using pJG:Rv3023/iscS.
DNA extraction and Southern blot analysis
Mycobacteria were treated overnight at 37 ◦C with SET buffer
[25% sucrose, 50 mM sodium EDTA and 50 mM Tris/HCl
(pH 8)] containing 3 mg/ml lysozyme. After the addition of
RNase (subsequent incubation at 37 ◦C for 30 min) and proteinase
K (subsequent incubation 55 ◦C for 30 min) DNA was extracted
with phenol/chloroform and ethanol-precipitated. For Southern
blot analysis, 4 μg of DNA was digested with AclI and AvrII
and separated by agarose gel electrophoresis. After denaturation
the DNA was blotted on to a Hybond N + membrane. For
probe labelling and detection the ECL direct nucleic acid
labelling and detection kit (GE Healthcare) was used following
the manufacturer’s recommendations. A PCR product spanning
Rv3026/trmU without iscS was used as the probe.
RNA extraction and PCR
For gene expression analysis, RNA was extracted with TRIzol®
(Invitrogen) and treated with DNase I (Roche) before generation
of the cDNA template. cDNA was synthesized using the
RevertAid First Strand cDNA Synthesis kit (Fermentas) using
random hexamer primers. cDNA corresponding to 10 ng of
input RNA was used in each RT (reverse transcription)–PCR
supplemented with specific primer pairs (200 nM each) listed
in Supplementary Table S2 and SYBR Green Master mix
(Applied Biosystems). qPCR (quantitative real-time PCR) was
performed with the 7900HT Fast Real-Time PCR system (Applied
Biosystems) with the following parameters: 50 ◦C for 2 min and
95 ◦C for 10 min, followed by 40 cycles of 95 ◦C for 15 s and
60 ◦C for 60 s. Melt curve analysis was used to confirm specific
amplification of each primer pair.
Y2H (yeast two-hybrid) assays
The Matchmaker Gal4 Two-hybrid System 3 (Clontech) was
used to screen for proteins that interact with IscSMtb and
IscSEc. The respective plasmids based on pGBKT7 and pGADT7
(Supplementary Table S1) were co-transformed into yeast strain
AH109 according to the recommendations of the manufacturer.
Transformants were plated on SD (synthetic defined) minimal
medium (− Leu/ − Trp) and subcultured on high stringency plates
[SD/ − Ade (adenine)/ − His/ − Leu/ − Trp/X-α-galactosidase].
Purification of His6-tagged IscSMtb
Mid-exponential-phase culture (2 litres) was induced with
0.5 mM IPTG and incubated for 12 h at 16 ◦C. E. coli BL21(DE3)
cells were lysed in lysis buffer [50 mM Tris/HCl (pH 8), 500 mM
NaCl, 5 mM imidazole, 10% (v/v) glycerol and 1% (w/v) Tween
20] using a French press. After clearance by centrifugation, the
lysates were incubated with 1 g of PrepEase resin (USB) for 1 h
at 4 ◦C followed by separation on a PolyPrep chromatography
column (Bio-Rad Laboratories). The resin was washed with two
column volumes of buffer containing 10 mM imidazole and eluted
with 250 mM imidazole. After dialysis against 25 mM Tris/HCl
(pH 7.5) and 100 mM NaCl the protein was further purified by
gel filtration on a HiLoad 16/60 Superdex 200 column (GE
Healthcare).
Pull-down experiments
Experiments were performed with S-tagged WhiB3, Acn or
ShdB expressed from pETduet-1 as prey and His-tagged IscSMtb
expressed from pQE80 as bait. Empty pQE80 was used as a
negative control. E. coli BL21(DE3) cultures (500 ml) were
grown and induced as described above. Prey and bait cultures
were mixed, and lysis and resin binding were performed as
described above [lysis buffer: 25 mM Tris/HCl (pH 8), 200 mM
NaCl, 5 mM imidazole and 2% (v/v) glycerol]. After elution
with lysis buffer containing 250 mM imidazole, proteins were
separated by SDS/PAGE (4–12% gel) and transferred on to a
nitrocellulose membrane. S-tagged proteins were detected using
an S-tag monoclonal antibody at a dilution of 1:5000 (Merck).
Enzyme assays
Enzyme assays with L-cysteine as substrate contained 200 mM
Tris/HCl (pH 7.5), 50 mM NaCl, 0.25 mM PLP and 0.5–100 mM
L-cysteine dissolved in water and 5 mM DTT. Before enzyme
assays for determining the activity of IscS with L-selenocysteine
were performed, L-selenocystine had to be reduced to obtain L-
selenocysteine. For this purpose L-selenocystine was first solved
in a water/methanol (1:2, v/v). Subsequently, the pH was increased
by the addition of two equivalents of a 1 M NaOH solution while
cooling on ice. NaBH4 was added in portions under stirring until
the yellow mixture became colourless. The pH was adjusted
to pH 5.5 to obtain the free amino acid instead of the sodium
salt. The L-selenocysteine assay mixtures contained 200 mM
Tris/HCl (pH 7.5), 50 mM NaCl, 0.25 mM PLP and 3.75–30 mM
L-selenocysteine. The enzyme assays were started by the addition
of purified protein (100 μg in 1 ml) and were performed at 37 ◦C.
Several 50 μl samples were collected over a period of 20 min, and
reactions were terminated by mixing each sample with 30 μl of
5% perchloric acid and 38% ethanol. After neutralization with
20 μl of 20 mM Tris/HCl (pH 8) buffer containing 23 mM K2CO3,
the precipitated salts were removed by centrifugation (16200 g
for 10 min at 22 ◦C). Subsequently, the product, L-alanine, was
quantified by ultra-high-pressure liquid chromatography as its
o-phthaldehyde derivative. Assays were linear over time and
proportional to the protein concentration applied.
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For Acn activity, exponentially growing cultures were lysed by
beadbeating with 0.1 mm zirconia beads in ice-cold assay buffer.
After centrifugation (16200 g for 10 min at 4 ◦C), Acn activity
was measured in the supernatant in a coupled enzymatic reaction
using an Acn activity assay kit (Sigma–Aldrich). SdhB (succinate
dehydrogenase) activity was measured according to the method
of Munujos et al. [22]. Whole-cell lysates (10 μl; 200 ng/μl total
protein) were added to 90 μl of reaction buffer in a 96-well plate
and colour development was monitored at 500 nm in a Tecan
M200 microplate reader at 30 ◦C.
Protein crystallization and X-ray data collection
Approximately 1000 buffer conditions were screened for protein
crystals with 10 mg/ml IscSTB in 25 mM Tris/HCl (pH 7.5)
and 100 mM NaCl. The best condition was refined using the
hanging-drop vapour-diffusion method in drops of 2–4 μl at
18 ◦C. Diffraction-quality crystals were grown in a crystallization
solution consisting of 0.2 M ammonium sulfate, 0.1 M Bis-
Tris (pH 5.5), 10% (w/v) PEG 3350 and 5% (v/v) glycerol.
All crystals were cryoprotected in reservoir mother liquor
supplemented with 25% (v/v) glycerol and directly flash-cooled
in liquid nitrogen. Diffraction data were collected on beamlines
PXII and PXIII of the Swiss Light Source (Villigen, Switzerland).
All data were indexed, scaled and integrated using XDS
[23].
Structure determination and model refinement
IscSMtb was crystallized in the P1 space group with unit
cell dimensions of approximately a = 66 Å (1 Å = 0.1 nm),
b = 78 Å, c = 93 Å, α = 94◦, β = 104◦ and γ = 99◦, with
four molecules in the asymmetric unit. Phase determinations
were carried out by molecular replacement using Phaser [24],
part of the CCP4 Suite [25]. IscSMtb was modelled on the
published structure of IscS from E. coli [36] with PDB code
3LVM used as search model. The initial molecular replacement
models were manually adjusted in COOT, part of the CCP4
Suite [25], and refined with REFMAC5 [26]. Structure figures
were prepared with PyMOL (http://www.pymol.org). All
crystallographic statistics are listed in Supplementary Table
S3 (http://www.biochemj.org/bj/459/bj4590467add.htm). Co-
ordinates and structure factors for IscSMtb have been deposited
in the PDB under accession code 4ISY.
LC–MS/MS
An FDR (false discovery rate) of 1%, a minimum peptide
Mascot score of 25 and a minimum of two matching peptides
per protein were used as the identification criteria for Mtb
proteins. A normalized spectrum count was used to compare
the relative abundance of proteins. A detailed description of the
LC–MS/MS methods used in the present study can be found
in the Supplementary Online Data (http://www.biochemj.org/bj/
459/bj4590467add.htm).
RESULTS
The iscSMtb mutant is microaerophilic, hypersensitive to H2O2
stress and displays impaired activity of Fe–S cluster-dependent
enzymes
The iscS gene of M. tuberculosis was predicted to be essential
for cell viability by high-density mutagenesis [27]. To create an
unmarked deletion we first complemented M. tuberculosis H37Rv
with pGA44:iscS, a plasmid carrying a tetracycline-repressible
pristinamycin-dependent promoter. We then deleted iscS using
pJG:Rv3026/trmU which contains the genes flanking iscS and
the sacB gene for counterselection. After selection on medium
containing sucrose, successful allelic exchange was confirmed
by Southern blotting (Figure 2A). Compared with the wild-
type strain, the growth rate of the complemented iscS strain
was slightly lower and the addition of tetracycline led to a
pronounced deceleration of growth (Figure 2B). However, even in
the presence of tetracycline, there was observable growth allowing
the conclusion that IscS is not fully essential. To confirm this we
performed a second deletion using pJG:Rv3026/trmU on a wild-
type background. After counterselection, small colonies were
visible after 10 weeks of incubation at 37 ◦C and the successful
deletion of iscS was confirmed by PCR (results not shown).
Complementation of this mutant was possible with both plasmids
expressing IscS from the strong HSP60 (heat-shock protein 60)
promoter (pMV261B:iscSMtb) or from the putative endogenous
promoter upstream of iscS (pMD31:iscSMtb). Incubating the
mutant strain for 3 months revealed a distinct smooth and
ruffled colony morphology which could be converted into the
typical rough and spread-out colony morphology of wild-type
M. tuberculosis upon complementation with iscS (Figure 2C).
Interestingly, it was reported previously that a whiB3-knockout
mutant showed similar colony morphology, and a defect in cord
formation appears to be a feature of both mutants [15]. These data
show that iscS is not essential on rich medium, but its deletion
leads to a slow-growth phenotype and altered morphology. When
subcultured several times in liquid medium the growth rate
could be increased and finally reached H37Rv wild-type levels.
However, when these bacteria were plated on solid medium, the
growth rate was again heavily reduced and the colonies were
smooth, indicating a stable phenotype.
The generation of the iscSMtb mutant allowed us to identify
characteristics associated with a putative role of IscS in Fe–
S cluster assembly. Incubation of wild-type, knockout and
complemented knockout mutant M. tuberculosis cells with 5 mM
H2O2 for 3 h showed increased sensitivity of the mutant strain
towards oxidative stress (Figure 3A). Further proof of a role
for IscS in protecting M. tuberculosis from oxidative stress
was obtained on overexpression of the protein from the strong
pristinamycin-dependent promoter as this rendered the cells
resistant to H2O2 (Figures 3A and 3B).
To test whether the deletion of iscSMtb leads to altered activity
of Fe–S cluster-dependent enzymes we quantified Acn activity
in mycobacterial whole-cell lysates (Figure 3C). The [4Fe–4S]
cluster of this TCA (tricarboxylic acid) cycle enzyme is essential
for the conversion of citrate into isocitrate. Compared with the
wild-type strain, the iscSMtb mutant displayed approximately
50% less Acn activity, which is comparable with the activity
seen in the iscS mutant of E. coli [8]. Acn activity could
be restored through complementation (Figure 3C). Equal total
amounts of Acn were identified by LC–MS/MS in the examined
whole-cell lysates, ruling out reduced enzymatic activity due to
different amounts of enzyme (Supplementary Figures S1A and
S1B at http://www.biochemj.org/bj/459/bj4590467add.htm). We
also tested for activity of the Fe–S protein SdhB in the respective
strains. This enzyme also showed impaired activity in the mutant
(Supplementary Figure S1C).
The biogenesis of Fe–S clusters is sensitive to oxygen since iron
and sulfide can be modified by oxygen or ROS (reactive oxygen
species), eventually leading to cluster decay. When grown under
microaerophilic conditions, the growth rate of the mutant could
be enhanced and was almost comparable with that of the H37Rv
wild-type strain grown under the same conditions, indicating that
IscS is needed for cluster assembly or repair under normal oxygen
conditions (Figure 3D).
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Figure 2 Unmarked deletion of iscS in M. tuberculosis
(A) Southern blot of M. tuberculosis H37Rv (wild-type) and complemented iscS::iscS DNA digested with AclI and AvrII. The latter site was genetically engineered between the flanking iscS genes
leading to the formation of two detectable DNA fragments of approximately 1.9 and 6.3 kb in the mutant and only one fragment of 8.2 kb in the wild-type. The iscS flanking genes served as the
probe. (B) Growth curves of M. tuberculosis H37Rv and iscS::iscS strain with and without anhydrous tetracycline (ATc). Down-regulation of IscS through anhydrous tetracycline leads to slower,
but detectable, growth. OD600, attenuance at 600 nm. (C) Colony morphology of M. tuberculosis H37Rv, mutant and complemented iscS strain after incubation for 3 months. The iscS strain
shows small colonies that have a smooth and ruffled colony morphology compared with the wild-type and complemented strains.
Putative targets of IscSMtb are Fe–S proteins with important
roles in the virulence of M. tuberculosis. Furthermore,
phagocytosis shifts the bacteria into redox-active cell
compartments, which are dedicated to the elimination of
microbes. We thus tested the iscS strain in THP-1 macrophage
and MRC-5 lung fibroblast virulence assays. At an MOI between
5 and 10, wild-type M. tuberculosis is cytotoxic for activated
macrophages as well as fibroblasts and this can be quantified
using cell viability assays [28,29]. After 72 h of infection, the
iscS strain was significantly less cytotoxic for macrophages and
fibroblasts than the H37Rv wild-type or the complemented mutant
strain, indicating an attenuated phenotype in vitro (Figure 3E).
It was shown recently that the deletion of trmU has
an effect on the intracellular redox state of E. coli [30].
To rule out the possibility that the phenotype we observed
for the iscS strain was not due to impaired TrmU
activity as a consequence of insufficient sulfur transfer,
we deleted trmU in M. tuberculosis (Supplementary Figure
S2A at http://www.biochemj.org/bj/459/bj4590467add.htm) and
performed Acn- and H2O2-sensitivity assays. The trmU strain
performed like wild-type M. tuberculosis in both assays indicating
that the impaired Fe–S protein activity we observed in the iscS
strain is independent from TrmU (Supplementary Figures S2B
and S2C).
Complementation with iscS of E. coli does not rescue the small
colony morphology or Acn activity of the iscSMtb mutant
The high conservation of iscS genes allowed for successful
heterologous complementation experiments in iscS mutants of
several organisms [10–12]. In order to identify distinct features
of the mycobacterial protein we also tried to complement the
iscSMtb strain by overexpressing the well-described IscS
protein of E. coli from a mycobacterial promoter. However, we
were not able to rescue the small colony morphology of the
knockout strain (Figure 4A). This failure for complementation
was not due to low transcription or expression levels of IscSEc
since we were able to detect and quantify the protein by LC–
MS/MS in the mycobacterial cytosol (Figure 4B). We also
tested for Acn activity in this IscSEc complemented mutant.
Expression of IscSEc did not restore the full activity of the enzyme
(Figure 3C).
IscSMtb uses both L-cysteine and L-selenocysteine as substrates
To rule out differences in enzyme kinetics as a possible
explanation for the failure of IscSEc in complementing iscSMtb,
we assayed for cysteine desulfurase activity of recombinant
IscSMtb. So far IscSMtb cysteine desulfurase activity was only
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Figure 3 Growth characteristics of iscS under various conditions and cytotoxicity assays
(A) Mycobacteria were exposed to 5 mM H2O2 and serial dilutions were plated before and after exposure. Colony-forming units (cfu) were counted after 4 weeks of incubation (wild-type strain and
complemented mutant) or after 3 months of incubation (iscS mutant). The knockout is more sensitive to H2O2, whereas overexpression of IscS protects from oxidative stress. (B) IscS mRNA levels
of the three strains correlate with survival during H2O2 exposure. Expression of IscSMtb from the pristinamycin-dependent promoter leads to higher levels of IscS-specific mRNA compared with IscS
mRNA levels of the wild-type strain. (C) Acn activity of whole cell lysates; the iscS mutant shows significantly less activity than wild-type and complemented mutant. Complementation with IscSEc
did not restore enzymatic activity. (D) Growth of the iscS strain is enhanced under microaerophilic conditions. Serial dilution (10-fold) of individual strains were spotted on 7H10 agar plates and
incubated under different growth conditions. (E) Activated THP-1 macrophages and MRC-5 lung fibroblasts were infected with mycobacteria at an MOI of 5 (macrophages) or 10 (fibroblasts). Cells
were incubated for 3 days and viability was measured by the addition of PrestoBlue® and subsequent determination of fluorescence at 560/590 nm. The deletion of iscS leads to better survival of
the eukaryotic cells indicating impaired virulence of the knockout strain in vitro. Results are means +− S.E.M. (unpaired two-tailed Student’s t test). ***P 0.001, **P = 0.01 and *P < 0.05.
shown indirectly by a shift of its UV–visible spectrum after
the addition of L-cysteine [16]. We quantified the product L-
alanine after the addition of different concentrations of L-cysteine
to the affinity-purified IscSMtb. Assuming Michaelis–Menten
kinetics, we determined a Km value of 6.1 mM (Figure 4C) and,
at a concentration of 12 mM L-cysteine, a specific activity of
0.31 μmol/min per mg, which is similar to previously published
data on IscSEc [31]. Several cysteine desulfurases, including
IscSEc, were shown to provide selenium for selenoproteins such
as FdhF (formate dehydrogenase H) and selenium-containing
tRNAs using L-selenocysteine as a substrate [32]. We were
interested in similar activity for IscSMtb and performed enzymatic
assays with this substrate. L-selenocysteine was generated from
reduced L-selenocystin as described in the Materials and methods
section. We were able to identify a high specific activity for
this substrate at a concentration of 7.5 mM L-selenocysteine
(Figure 4D). At higher concentrations, enzyme activity was
decreased most probably due to acidification of the reaction buffer
by the substrate, which has a pH of 5.5 (results not shown).
However, we could clearly show that IscSMtb is capable of
using both L-cysteine and L-selenocysteine as substrates. These
data indicate that, despite similar enzymatic activities, IscSMtb is
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Figure 4 Complementation of iscS with iscS from M. tuberculosis or E. coli
(A) Individual plasmids were transformed in the iscS strain or H37Rv wild-type and incubated for 6 weeks. Expression of IscSMtb restored normal growth in the mutant, whereas expression of
IscSEc leads to the same slow-growth phenotype seen in the mutant transformed with the empty vector (pMV261B). (B) Quantification of IscSEc expressed in M. tuberculosis. Proteins of the cell
lysate were separated by SDS/PAGE and the band at 45 kDa was examined by LC–MS/MS as described in the Materials and methods section. The mycobacterial tryptophan synthase TrbP was
identified and quantified in the same gel slice and functions as a control protein of comparable mass. Representative data from three individual experiments are shown. (C) Michaelis–Menten kinetics
of IscSMtb with L-cysteine as substrate. (D) Time-dependent conversion of L-selenocysteine into L-alanine by IscSMtb.
functionally distinct from its E. coli counterpart upon expression
in the mycobacterial host.
IscSMtb, but not IscSEc, interacts with several mycobacterial Fe–S
and sulfur-accepting proteins
An intracellular excess of free iron and sulfur is toxic for most
bacteria and eukaryotes. Thus, in the IscS proteins examined
so far, sulfur is liberated from cysteine and transferred to the
scaffold protein IscU [33]. Since an IscU homologue is absent
from the mycobacterial ISC operon, we were interested in the
direct interaction of IscSMtb with putative sulfur-accepting Fe–
S proteins. IscSMtb is capable of reconstituting the [4Fe–4S]
cluster of apo-WhiB3, a mycobacterial transcriptional regulator,
in vitro [16]. Using Y2H assays we were able to show an
interaction of both proteins (Figure 5A). Furthermore, interactions
were identified for other known Fe–S protein targets of the
ISC system, such as the enzymes Acn (Rv number Rv1475c),
SdhB (Rv number Rv3319), FdhF (Rv number Rv2900c) and
the SirA (sulfite reductase; Rv number Rv2391). In addition,
IscSMtb interacts with the non-Fe–S protein and mycobacterial
ISC operon member TrmU (Figure 5A). Y2H assays were
repeated with switched vectors in which IscSMtb was fused to
the binding domain of the reporter system (pGBKT7-IscSMtb)
and mycobacterial Fe–S proteins to the activating domain of
the reporter plasmid pGADT7. These experiments gave identical
results (not shown; see Supplementary Table S1 for the plasmid
constructs).
Protein interactions identified in the Y2H experiments were
confirmed for three mycobacterial Fe–S proteins (WhiB3, Acn
and SdhB) by in vitro pull-down experiments. S-tagged Fe–
S proteins overexpressed in E. coli were bound to His-tagged
IscSMtb and captured on nickel resin. Protein complexes could
be identified after immunoblotting and detection with an anti-S-
tag antibody (Figure 5B).
To identify reasons for the failure of IscSEc to rescue the small
colony phenotype of iscSMtb we repeated the Y2H experiments
using IscSEc. First, we confirmed published experiments on the
positive interaction of IscSEc with IscUEc indicating that our
Y2H assay can be used to test for putative protein interactions
of IscSEc with Fe–S proteins [33] (Table 1). When IscSEc was
tested for interaction with mycobacterial Fe–S proteins, a positive
result could only be obtained for IscSEc and WhiB3. In contrast
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Figure 5 IscSMtb interacts with several mycobacterial Fe–S proteins
(A) Individual plasmids were co-transformed into yeast cells and plated on SD/ − Leu/ − Trp and SD/ − Ade/ − His/ − Leu/ − Trp media. All transformants grew well on SD/ − Leu/ − Trp plates
showing successful co-transformation of plasmids. When subcultured on SD/ − Ade/ − His/ − Leu/ − Trp/ X-α-galactosidase medium, only the positive interaction of IscSMtb with mycobacterial
proteins and subsequent transcription of reporter genes allows for growth of the auxotrophic yeast strain. Gal4 activation through protein–protein interaction leads to the development of blue-coloured
(dark in the Figure) colonies giving further proof of robust association of IscSMtb with Fe–S proteins. IscSMtb strongly interacts with several mycobacterial Fe–S proteins and with the non-Fe–S
protein TrmU. pGADT7:T and pGBKT7:53 are positive control vectors that contain the SV40 large T-antigen and the murine p53 protein, which strongly interact in Y2H assays. (B) In vitro pull-down
experiments with S-tagged SdhB, Acn and WhiB3. Overexpressed proteins were bound to His-tagged IscSMtb and captured on nickel resin. Protein complexes were identified after immunoblotting
and detection with an anti-S-tag antibody.
with IscSMtb, IscSEc failed to interact with SdhB, SirA and Acn.
Thus the negative complementation phenotype that we observed
for the iscSMtb::iscSEc strain could be due to failure of IscSEc
in interacting with sulfur-accepting proteins of M. tuberculosis.
We also tested for interaction of IscSMtb with IscU of E.
coli. Although IscSMtb interacts with several mycobacterial
Fe–S proteins, an interaction with this central sulfur-accepting
protein of Gram-negative bacteria was not detectable (Table 1).
The mycobacterial SUF operon contains an IscU/NifU-like gene
product (Rv1465) with 24% homology with the respective E. coli
protein. This protein also failed to interact with IscSMtb (Table 1).
The reason for these negative results could be a C-terminal α-helix
absent from IscSMtb, a part of the protein that is mandatory for
the IscS–IscU interaction in E. coli (see the structural data below)
[34,35]. Of note, not only IscSMtb, but also the Fe–S acceptor
protein WhiB3, failed to interact with the putative IscU/Rv1465
protein (Table 1).
Overall protein fold and active site are conserved in IscSMtb and
IscSEc
To better define the distinct characteristics of the IscSMtb
protein we crystallized the protein and solved the structure at
2.6 Å resolution. The crystallographic data collection statistics
are given in Supplementary Table S3. As expected, IscSMtb
forms a homodimer with the typical large and small domains
seen in most PLP-dependent enzymes (Supplementary Figure S3
http://www.biochemj.org/bj/459/bj4590467add.htm) [36].
IscSMtb and IscSEc share similar secondary structure and
topology except for a C-terminal α-helix absent from IscSMtb
as shown by superimposition of the structures in Figure 6(A).
Residues of the C-terminal α-helix were shown previously to be
essential for the IscS–IscU interaction in E. coli [34,35].
In its active-site pocket, IscS catalyses the desulfuration of
cysteine yielding alanine. This involves the formation of a Schiff
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Table 1 IscSEc interacts with IscUEc, but not with the mycobacterial SdhB, SirA or Acn
Individual plasmids were co-transformed into yeast cells and plated on SD/ − Leu/ − Trp and SD/ − Ade/ − His/ − Leu/ − Trp media. As all transformants grew well on SD/ − Leu/ − Trp plates,
the Table displays growth phenotypes of co-transformants after subcultivation on SD/ − Ade/ − His/ − Leu/ − Trp medium. IscSEc failed to interact with mycobacterial Fe–S proteins except for
WhiB3. Additionally, IscSMtb failed to interact with the scaffold protein IscUEc, the major acceptor of IscS-derived sulfur in Gram-negative bacteria, and IscSMtb did not interact with Rv1465, a
mycobacterial IscU/NifU homologue which is part of the SUF operon. pGADT7:T and pGBKT7:53 are positive control vectors that contain the SV40 large T-antigen and the murine p53 protein which
strongly interact in Y2H assays. + , growth; − , no growth; nd, not determined.
Vector pGBKT7:IscUEc pGBKT7:whiB3 pGBKT7:sdhB pGBKT7:Acn pGBKT7:sirA pGBKT7:IscSMtb pGBKT7:53
pGADT7:iscSEc + + − − − nd −
pGADT7:iscSMtb − + + + + nd −
pGADT7:Rv1465 nd − nd nd nd − −
pGADT7:T − − − − − − +
Figure 6 Structural alignment of IscSMtb (blue) and IscSEc (green) monomers
(A) Both proteins share a similar secondary structure and topology except for the most C-terminal helix of IscSEc which is missing in IscSMtb (black arrow). The PLP cofactor is displayed in red.
(B) Magnified view of the PLP cofactor in the highly conserved active-site pocket. Ec, E. coli.
base between the substrate cysteine residue and the cofactor
PLP followed by nucleophilic attack of the bound cysteine
residue by Cys329 in IscSMtb and Cys328 in IscSEc. The highly
homologous pockets of both proteins are rich in charged and/or
polar amino acid side chains. The PLP group is anchored via
an internal Schiff base with Lys205 in M. tuberculosis and Lys206
in E. coli (Figure 6B), and further stabilized by hydrogen bonds
with identical amino acids in both enzymes indicating similar
substrate-binding and catalysis mechanisms. Key to the versatile
sulfur transfer activity of IscS proteins is the dual role of the
active-site cysteine, which participates in catalysis of sulfur from
the substrate cysteine and in transfer of a subsequently bound
persulfide to effector proteins. The active-site cysteine residue is
organized in a large and flexible loop, which does not display
electron density in either the IscSEc structure (Cys328–Lys333) or
our IscSMtb structure (Cys329–Ala334). However, the loop flanking
amino acids, which are believed to ensure the necessary flexibility
of the IscS loop, are conserved in both proteins, again indicating
similar sulfur transfer mechanisms.
The surface amino acid composition of IscSMtb and IscSEc are
highly distinct
Since IscSEc partially failed to interact with mycobacterial
Fe–S proteins, we tested for differences in the properties of
surface amino acids of the two IscS proteins using the Chimera
software [37]. Interestingly, the electrostatic surface potential is
dramatically different in large areas of the proteins (Figure 7),
which is mirrored by net charge calculations of − 34 e for IscSMtb
and − 12 e for IscSEc. This is most pronounced in the vicinity of
the IscSMtb active site, where large patches of the protein display
a negative charge which is not the case for IscSEc. Intriguingly,
the polarity of the surface amino acids is much more conserved
in the two proteins with predominantly hydrophilic side chains
as expected for cytosolic proteins. IscSMtb shows only a slightly
higher content of hydrophobic areas as shown in Supplementary
Figure S4 (http://www.biochemj.org/bj/459/bj4590467add.htm).
The N-terminal part of IscSMtb is essential for protein–protein
interactions
To map interaction domains of IscSMtb with sulfur-accepting
proteins we performed deletion-mapping experiments of the C-
terminus and probed these shorter versions of the protein in
Y2H assays. It was found that large parts of the C-terminus
could be deleted without affecting protein–protein interactions.
However, putative regions between amino acids 68 and 143 are
essential for interaction (Supplementary Figure S5A (http://www.
biochemj.org/bj/459/bj4590467add.htm). This N-terminal part
of IscSMtb is rich in arginine and tryptophan residues and a
unique WXRRX5RRRX16W motif can be found in IscS proteins
of actinomycetes, but not in proteins of other Gram-positive
or Gram-negative bacteria (Supplementary Figure S5A). The
arginine residues of the two IscS monomers form a large
c© The Authors Journal compilation c© 2014 Biochemical Society
476 J. Rybniker and others
Figure 7 The electrostatic potential of the IscSMtb and the IscSEc dimer
Negatively charged amino acids prevail on the IscSMtb surface which is the opposite for IscSEc. The approximate position of the active-site loop, which does not show electron density in both
structures, is displayed by yellow labelling of the loop flanking the N- and C-terminal amino acids. Red, negative charge; blue, positive charge.
surface-exposed hydrophilic patch, whereas two tryptophan
residues of each monomer come together in a cleft formed
by the dimer interface (Supplementary Figures S5B and
S5C). The structural composition of this part of the
mycobacterial protein is clearly distinct from its E. coli
counterpart where interaction-sensitive arginine residues are
primarily found towards the C-terminus [38]. In an attempt
to identify the surface amino acids that are essential for
proper IscSMtb function and protein–protein interaction, we
performed structure-guided alanine-scanning mutagenesis on
IscSMtb, choosing polar and surface-exposed amino acids
in the interaction-sensitive IscSMtb regions. As shown in
Supplementary Figure S6(A) (http://www.biochemj.org/bj/459/
bj4590467add.htm), several single, double and triple point
mutations were generated and tested for complementation in
the slow-growing iscSMtb strain. Both tryptophan residue
mutations led to only partial complementation. Alanine exchange
of the first two arginine residues in the motif had no effect
on complementation, whereas triple mutations of Arg90–Arg92
led to complete abrogation of IscS complementation on the
iscS background. However, when expression levels of these
mutated proteins were quantified by LC–MS/MS, significantly
smaller amounts of protein could be detected compared with
the wild-type protein, indicating that the mutated amino acids
are essential for protein stability (Supplementary Figure S6B).
To rule out promoter mutations in the mycobacterial expression
plasmid that might explain the low levels of expressed protein,
we individually cloned the mutated IscSMtb genes into an E. coli
expression vector and purified the proteins from E. coli lysates.
The resulting expression levels of the mutated proteins were
equally low in comparison with the wild-type protein (results
not shown). Again, this indicates that the affected amino acids are
important for structural integrity of IscSMtb making it difficult
to draw conclusions on their individual role in protein–protein
interactions.
DISCUSSION
In the present study we generated genetic, structural and
functional data to characterize the role of the mycobacterial
cysteine desulfurase IscS in Fe–S cluster biogenesis. The largely
depleted and unusual ISC operon found in mycobacteria and other
Gram-positive bacteria initially led to the assumption that these
organisms rely exclusively on the SUF system for Fe–S cluster
assembly and repair [13,39]. However, we provide evidence that
the deletion of iscS in M. tuberculosis leads to a phenotype which
is associated with dysfunctional Fe–S cluster assembly. Since
the typical scaffold proteins for cluster assembly and transfer
are absent from the actinobacterial ISC operon, two scenarios
for IscSMtb-mediated Fe–S cluster assembly are conceivable: (i)
IscSMtb makes use of so far unidentified mycobacterial scaffold
proteins or scaffold proteins of the SUF system; or (ii) a direct
interaction of IscSMtb and apo-acceptor proteins is involved in
sulfur transfer mediated by IscSMtb.
The latter theory of scaffold-protein-independent cluster
assembly is supported by data on the mutational analysis of the
ISC operon of Gram-negative bacteria. The complementation of
an E. coli strain lacking the complete ISC operon with IscSEc
alone partially restored the activity of some Fe–S-dependent
enzymes, clearly indicating that IscS is capable of contributing
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to Fe–S cluster formation even in the absence of the scaffold
protein IscU [40]. It is well known that IscS has a general Fe–
S cluster biogenesis-independent role in sulfur trafficking. A
downstream gene product of both the C. difficile ISC operon
and the M. tuberculosis ISC operon is the 2-thiouridylase TrmU
(Figure 1), a non-Fe–S enzyme that has been shown to receive
sulfur from IscS for the formation of 2-thiouridine in E. coli tRNA
[41]. Another example of sulfur donation by IscS is thiamine
biosynthesis involving the non-Fe–S protein ThiI [42]. These
data clearly indicate that IscS can be a direct sulfur donor to
several effector proteins. It is thus conceivable that IscS provides
sulfur not only to non-Fe–S proteins by direct protein interaction,
but also to the apo-forms of Fe–S proteins. Our protein–protein
interaction studies, together with the data on impaired Acn and
SdhB activity in the mutant strain, support this theory which
represents a novel and so far undescribed mechanism of direct
sulfur transfer to Fe–S proteins.
This raises the question of why M. tuberculosis performs IscU-
independent cluster assembly. It was recently shown that the ISC-
system in E. coli is inactivated by ROS, whereas the SUF system is
induced and active only under oxidizing stress mediated by ROS
[43]. The labile element within the ISC operon was identified
as IscU. Clusters built on this protein were easily oxidized and
destroyed, whereas IscS itself retained full activity when exposed
to ROS [3,43]. Intracellular mycobacteria encounter a hostile
environment in which macrophages constantly produce ROS and
reactive nitrogen species that have potent antimicrobial activity.
M. tuberculosis has evolved several strategies to withstand this
stress and to persist within human phagocytes [44]. A ROS-labile
IscU protein may be unfavourable for survival in this intracellular
niche, and IscS-driven cluster assembly independent of IscU could
be a requisite to promote intracellular survival. Our data showing
that high levels of IscS protect from H2O2 killing support this
theory.
We were surprised by our finding that IscSMtb converted L-
selenocysteine into L-alanine in a highly efficient and specific
way. In fact, the activity of the enzyme was higher in the presence
of L-selenocysteine than in the presence of L-cysteine. The M.
tuberculosis genome lacks genes involved in the biogenesis
of selenoproteins including selenocysteine-specific tRNAs and
selenophosphate synthase, which was shown to be an acceptor
of IscS-derived selenium in other organisms [45]. However, in
the presence of selenium, bacteria synthesize L-selenocysteine
through the cysteine biosynthesis pathway leading to its unspecific
misincorporation into proteins [46]. This effect is even more
pronounced in bacteria lacking specific selenium-incorporation
pathways, as is the case for M. tuberculosis [46]. Owing to the
high reduction potential, free L-selenocysteine is considered toxic
to the cell, thus IscSMtb could be involved in the detoxification
of this highly reactive amino acid.
Another unsolved problem in mycobacterial Fe–S assembly is
the source of iron. In E. coli, there is some evidence that the
bacterial frataxin CyaY may function as an iron donor or at least
as an iron-sensing protein during Fe–S cluster assembly on IscU.
In addition, there are in vitro data implying that IscA may provide
iron for the E. coli ISC system [2]. However, no CyaY or IscA
homologue can be identified in the mycobacterial genome. Further
studies are needed to answer these important questions.
In the present study, we have addressed the strong genomic
variability of ISC operons found in different organisms. This
variability implies distinct Fe–S cluster-assembly mechanisms
and structural differences of the respective ISC proteins. In fact,
the IscSMtb structure we solved mirrors adaptations made in
response to an operon devoid of scaffold proteins since the protein
lacks a C-terminal helix that is involved in the formation of the
IscS–IscU complex in E. coli [35]. Interestingly, it was shown
previously that E. coli IscU binds to an IscS region rich in
amino acids with negatively charged residues [34]. Consistent
with charge-dependent protein–protein interactions, it is the IscU
mutation K103E (positive to negative) that abrogates the IscS–
IscU interaction. We were able to show in the present study that
the surface of IscSMtb predominantly contains negatively charged
residues and the electrostatic potential, especially in the vicinity
of the active site, is highly divergent in IscSMtb and IscSEc. This
overall negative net charge in IscSMtb may be a requirement
for sulfur transfer to Fe–S proteins, which often carry positively
charged Fe–S active sites [47,48].
In conclusion, the results of the present study provide insight
into a novel mechanism by which M. tuberculosis copes with
environmental stress through Fe–S cluster biogenesis and/or
repair by the versatile enzyme IscS. It is evident that IscS plays a
decisive role in sulfur trafficking and sulfur metabolic pathways
which are essential for survival and virulence of M. tuberculosis
[49]. Its unique structural features not present in IscS proteins of
many other bacteria or the human IscS-like protein may provide
opportunities for therapeutic interventions against this important
pathogen.
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MATERIALS AND METHODS
LC–MS/MS
Gel pieces containing protein of the appropriate molecular
mass were first reduced and alkylated (DTE/iodoacetamide).
Proteolytic digestion was performed overnight at 37 ◦C using
trypsin in 50 mM ammonium bicarbonate (pH 8.3). Peptides were
then extracted from gels and concentrated by SpeedVac before
LC–MS/MS measurements. Dried samples were resuspended
in LC–MS/MS loading solvent (2% acetonitrile and 0.1%
formic acid) and separated by HPLC (Ultimate 3000; Dionex).
Samples were first captured on a capillary pre-column (Magic
C18; 3 μm; 200 Å; 2 cm×100 μm) before analytical separation.
An 80 min biphasic gradient was run, starting from 100% solvent
Figure S1 LC–MS/MS quantification
(A) LC–MS/MS quantification of Acn from M. tuberculosis whole-cell lysates. (B) The heat-shock protein GroES was quantified in the same samples and used as a loading control. (C) SdhB activity
of whole-cell lysates; the iscS mutant shows significantly less activity than wild-type and complemented mutant. Results are means +− S.E.M. **P < 0.01. N.S.: not significant.
A (2% acetonitrile and 0.1% formic acid) to 90% solvent
B (90% acetonitrile and 0.1% formic acid) on a capillary
column (Nikkyo Technos; C18; 3 μm; 100 Å; 15 cm×75 μm
internal diameter; 250 nl/min). Online MS detection was
performed on an Orbitrap Elite mass spectrometer (Thermo
Scientific) using the data-dependent acquisition mode with
dynamic exclusion. For each MS scan, the 20 most intense
detected ions were fragmented and then excluded for the following
30 s.
Experimentally generated data were submitted to protein
database search through Proteome Discoverer 1.3 and Mascot 2.3
search engine using the UniProt (version Swissprot_2012_03) or
TubercuList (Release 25) database. Scaffold 3 Viewer was used
to finally compile data results.
1 To whom correspondence should be addressed (email jan.rybniker@epfl.ch).
Co-ordinates and structure factors for Mycobacterium tuberculosis IscS have been deposited in the PDB under accession code 4ISY.
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Figure S2 Unmarked deletion of trmU in M. tuberculosis
(A) PCRs to confirm successful deletion. PCR1 spans trmU and parts of the flanking genes.
PCR2 targets trmU. Acn activity (B) and H2O2 sensitivity (C) of the trmU mutant and wild-type
M. tuberculosis. Results are means +− S.E.M. WT, wild-type.
Figure S3 Overall structure of the IscSMtb dimer
The monomers of the dimer are shown in red and blue. Like many PLP-dependent enzymes,
each IscSMtb monomer consists of a small and a large domain. Small domains cover amino
acids 1–12 and 261–386, which are shown in light blue and light red. The PLP-binding Lys205
and the PLP cofactor are labelled in yellow.
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Figure S4 Surface hydrophobicity representation of IscSMtb and IscSEc structures (PDB codes 4ISY and 1P3W)
Blue areas represent hydrophilic amino acids, whereas orange represents areas that are more hydrophobic. The approximate position of the active-site loop, which does not show electron density in
both models, is displayed by yellow labelling of the loop flanking the N- and C-terminal amino acids.
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Figure S5 Deletion mapping of domains essential for IscS–protein interaction
(A) Upper panel: stepwise deletion of the N-terminal part of the protein was performed and the shortened genes were probed in Y2H assays with two mycobacterial Fe–S proteins (SdhB and FdhF).
The N-terminal part up to Asp134 is essential for protein interaction. The sequence between Gly68 and Asp134 was aligned with the respective sequence of IscSEc. Lower panel: alignment of IscS
sequences of different bacterial species and the human IscS homologue. M. marinum, Mycobacterium marinum; M. smegmatis, Mycobacterium smegmatis; S. viridans, Streptococcus viridans; S.
aureus, Staphylococcus aureus. The WXRRX5RRRX16W motif, that is highly conserved in actinomycetes which harbour a reduced ISC operon devoid of scaffold proteins, is indicated in blue. His100
is part of the active-site pocket and conserved in all species. (B) Top view of the IscSMtb dimer (monomers in light and dark grey) with highlighted WXRRX5RRRX16W motif. Arginine residues are
green and tryptophan residues are yellow. (C) Magnified and side view of the same region. Colour coding as in (B).
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Figure S6 Mutations performed on IscSMtb by alanine scanning and the phenotype of iscS strains overexpressing these mutated proteins with regard to
growth rate
(A) Alanine exchange of the active-site Cys329 abrogates IscS activity and the growth rate of this strain (C329A) is as slow as that of the non-complemented iscS strain. Similar results were
obtained for the W81A, W109A and the R90-92A mutants. (B) When the expression levels of these mutated proteins were quantified by LC–MS/MS, only IscSMtb C329A showed levels comparable
with the wild-type protein. Representative data from three individual experiments are shown.
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Table S1 Plasmids used in the present study
HSP60, heat-shock protein 60.
Plasmid Description Source/reference
pQE80L Expression vector carrying the cis-laqIq repressor gene Qiagen
pQE80:iscSMtb Expression of His6-tagged IscSMtb The present study
pQE80:iscSEc Expression of His6-tagged IscSEc The present study
pETduet-1 Allows expression of S-tagged proteins Merck
pJG1100 Suicide vector for selection of recombinants and the sacB counterselectable marker [1]
pJG:Rv3026/trmU pJG1100 carrying the iscS flanking genes Rv3026 and trmU The present study
pJG:Rv3023/iscS pJG1100 carrying the trmU flanking genes Rv3023 and iscS The present study
pGA44 Expression plasmid carrying a tetracycline-repressible promoter based on pFRA44 [2] [3]
pGA44:iscS Plasmid bringing iscS under control of the tetracycline-repressible pristinamycin-dependent promoter The present study
pMV261 Mycobacterial shuttle vector, HSP60 promoter for protein expression [4]
pMV261B pMV261 cut with XbaI and BamHI, PCR product of primers 5 and 6 introduced (see list above): avoids N-terminal
fusion of expressed proteins with HSP60-derived amino acids
The present study
pMV261B:iscSMtb Expresses IscSMtb from HSP60 promoter The present study
pMV261B:iscSEc Expresses IscSEc from HSP60 promoter The present study
pMD31 Mycobacterial shuttle plasmid [5]
pMD31:iscSMtb iscS gene with upstream intergenic region for complementation The present study
pGADT7 Yeast two-hybrid vector Clontech
pGBKT7 Yeast two-hybrid vector Clontech
pGADT7:T Y2H control vector, fusions between the Gal4 activation domain and SV40 large T-antigen Clontech
pGBKT7:53 Y2H control vector, fusions between the Gal4 DNA-binding domain and murine p53 Clontech
pGADT7:iscSMtb IscSMtb fusion with Gal4 activation domain The present study
pGADT7:iscSEc IscSEc fusion with Gal4 activation domain The present study
pGADT7:whiB3 WhiB3 fusion with Gal4 activation domain The present study
pGADT7:sdhB SdhB fusion with Gal4 activation domain The present study
pGADT7:sirA SirA fusion with Gal4 activation domain The present study
pGADT7:fdhF FdhF fusion with Gal4 activation domain The present study
pGADT7:acn Acn fusion with Gal4 activation domain The present study
pGADT7:trmU WhiB3 fusion with Gal4 activation domain The present study
pGADT7:Rv1456 Rv1465 (mycobacterial IscU homologue) fusion with Gal4 activation domain The present study
pGBKT7:whiB3 WhiB3 fusion with Gal4 DNA-binding domain The present study
pGBKT7:sdhB SdhB fusion with Gal4 DNA-binding domain The present study
pGBKT7:sirA SirA fusion with Gal4 DNA-binding domain The present study
pGBKT7:fdhF FdhF fusion with Gal4 DNA-binding domain The present study
pGBKT7:acn Acn fusion with Gal4 DNA-binding domain The present study
pGBKT7:trmU TrmU fusion with Gal4 DNA-binding domain The present study
pGBKT7:iscUEc IscUEc fusion with Gal4 DNA-binding domain The present study
pGBKT7:Rv1465 Rv1465 (mycobacterial IscU homologue) fusion with Gal4 DNA-binding domain The present study
pET:whiB3 Expression of S-tagged WhiB3 The present study
pET:acn Expression of S-tagged Acn The present study
pET:sdhB Expression of S-tagged SdhB The present study
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Table S2 Primers used in the present study
qPCR, quantitative PCR.
Primer number Construct Primer sequence (5′→3′)
1 pQE80:iscSMtb TCACCATCACGGATCCGCCTACCTGGATCA
2 TCAGCTAATTAAGCTTTCATCGGGATGCTC
3 pQE80:iscSEc TCACCATCACGGATCCAAATTACCGATTTATC
4 TCAGCTAATTAAGCTTTTAATGATGAGCCCATTC
5 pMV261B GATCTTTAAATCTAGAGGTGACCACAACGA
6 TCTGCAGCTGGATCCCATATGTGCGAAGTGATTCCT
7 pMV261B:iscSMtb TCACTTCGCACATATGGCCTACCTGGATCACGCT
8 AGCTGGATCCCATATGTCATCGGGATGCTCCCG
9 pMV261B:iscSEc TCACTTCGCACATATGAAATTACCGATTTATC
10 AGCTGGATCCCATATGTTAATGATGAGCCCATTC
11 pMD31:iscSMtb CGACTCTAGAGGATCCCCGCAGTCACCGAACAC
12 CGGTACCCGGGGATCCTCATCGGGATGCTCCCG
13 pGADT7:iscSMtb GGAGGCCAGTGAATTCGCCTACCTGGATCA
14 CGAGCTCGATGGATCCTCATCGGGATGCTC
15 pGADT7::iscSEc GGAGGCCAGTGAATTCAAATTACCGATTTATCTC
16 CGAGCTCGATGGATCCTTAATGATGAGCCCATTC
17 pGBKT7:whiB3 GAATTCCCGGGGATCCCACAGCCGGAGCAG
18 GCAGGTCGACGGATCCTTAAGCTGTGCGGC
19 pGBKT7::sdhB GAATTCCCGGGGATCCTGAGCGTCGAGCCGGACGTCGA
20 GCAGGTCGACGGATCCTCAGCGGGTGAACATCAGC
21 pGBKT7:fdhF GAATTCCCGGGGATCCTGTACGTTGAGGCGGTGAGGT
22 GCAGGTCGACGGATCCCTAGGCCGTTGGCTCCAATCGCA
23 pGBKT7:acn GAATTCCCGGGGATCCTGACTAGCAAATCTGTGAA
24 GCAGGTCGACGGATCCTCAGCCTGACTTCAGTATGT
25 pGBKT7:sirA GAATTCCCGGGGATCCTGTCCGCGAAGGAGAAC
26 GCAGGTCGACGGATCCTCATCGCAGGTCGTCCT
27 pGBKT7:trmU GAATTCCCGGGGATCCTGAAAGTTCTCGCC
28 GCAGGTCGACGGATCCTCAAGCCCCGGGGT
29 pGBKT7:iscUEc GAATTCCCGGGGATCCCTTACAGCGAAAAAGTTATC
30 GCAGGTCGACGGATCCTTATTTTGCTTCACGTTTGC
31 pGBKT7:Rv1465 GAATTCCCGGGGATCCTGACGTTGCGTCTGGA
32 GCAGGTCGACGGATCCTCAGCCGGTGCGCTGGTT
33 pGADT7:whiB3 GGAGGCCAGTGAATTCCCACAGCCGGAGCA
34 CGAGCTCGATGGATCCTTAAGCTGTGCGGC
35 pGADT7:acn GGAGGCCAGTGAATTCACTAGCAAATCTGTGAACT
36 CGAGCTCGATGGATCCTCAGCCTGACTTCAGTATGTT
37 pGADT7:sdhB GGAGGCCAGTGAATTCAGCGTCGAGCCGGACGTCGA
38 CGAGCTCGATGGATCCTCAGCGGGTGAACATCAGC
39 pGADT7:fdhF GGAGGCCAGTGAATTCTACGTTGAGGCGGTGAGGT
40 CGAGCTCGATGGATCCCTAGGCCGTTGGCTCCAAT
41 pGADT7:sirA GGAGGCCAGTGAATTCTCCGCGAAGGAGAACCCCCA
42 CGAGCTCGATGGATCCTCATCGCAGGTCGTCCTCCT
43 pGADT7:trmU GGAGGCCAGTGAATTCAAAGTTCTCGCCGCGATGA
44 CGAGCTCGATGGATCCTCAAGCCCCGGGGTTGCCG
45 pGADT7:Rv1465 GGAGGCCAGTGAATTCACGTTGCGTCTGGAGCAGAT
46 CGAGCTCGATGGATCCTCAGCCGGTGCGCTGGTTTC
47 pGADT7:iscSA324 CGAGCTCGATGGATCCTCATGCAATCAACACATGCGAG
48 pGADT7:iscSV285 CGAGCTCGATGGATCCTCAAACATCGTCAATCTC
49 pGADT7:iscST222 CGAGCTCGATGGATCCTCAGGTGACGTCGCGGCGCAG
50 pGADT7:iscSD134 CGAGCTCGATGGATCCTCAGTCGTCGTGGCTCTGC
51 pGADT7:iscSG68 CGAGCTCGATGGATCCTCAGCCGCCCGCGGTGAAG
52 pET:whiB3 AAGGAGATATACATATGCCACAGCCGGAGCAGCT
53 CTTTACCAGACTCGAGAGCTGTGCGGCGGATG
54 pET:acn AAGGAGATATACATATGACTAGCAAATCTGTGAA
55 CTTTACCAGACTCGAGGCCTGACTTCAGTATGTT
56 pET:sdhB AAGGAGATATACATATGAGCGTCGAGCCGGACGT
57 TTTACCAGACTCGAGGGTACCGCGGGTGAACATCAGCG
58 pJG:Rv3026/trmU TCGACTCTAGACTTAATTAAATGAGCGCTCCCGCA
59 GAGCATATGCCTAGGCATGACGCACCTAGA
60 TGCGTCATGCCTAGGCGATGAAAGTTCTCG
61 GTACCCGGGGGCGCGCCTCAAGCCCCGGGGTT
62 pJG:Rv3023/iscS GACTCTAGACTTAATTAATCGTCGCTGCACACCAGC
63 CGAGCATATGCCTAGGCATCGGGATGCTCCC
64 CATCCCGATGCCTAGGTGACTCGGCGCCAAATCA
65 GTACCCGGGGGCGCGCCATTCGGCGTCGGGCT
66 pGA44:iscS GCCTGAATGCCTAGGATGGCCTACCTGGAT
67 AAGTTATAACCTAGGTCATCGGGATGCTCC
68 Target, flanking trmU genes GGGCGACATCCCGGTCTCT
69 CGGATCATTGCGTCTCTCGCT
70 Target, trmU CTCGCGGGGCTGTTGTTC
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Table S2 Continued
Primer number Construct Primer sequence (5′→3′)
71 CGACAGCCGGGCGTAGTG
72 qPCR iscSMtb GACGGACTCGAGGAAAACAG
73 AAAGTGAAGTGCGCGTTACC
74 qPCR sigA TGGACTCATCGATGTTCTTCC
75 TAGGGCTCACCGACCTCTAA
76 Mutagenesis C329A AACCGGATCGGCCGCCACGGCAGGTGTAG
77 CTACACCTGCCGTGGCGGCCGATCCGGTT
78 Mutagenesis W81A GGCTGTCAAAGGTATCTATGCCGCACGCCGCG
79 CGCGGCGTGCGGCATAGATACCTTTGACAGCC
80 Mutagenesis W109A CTGGACTCGGTGAACGCCCTCGTGGAACACGAA
81 TTCGTGTTCCACGAGGGCGTTCACCGAGTCCAG
82 Mutagenesis R83A/R84A GGTATCTATTGGGCAGCCGCCGATGCGGAGCCGCAC
83 GTGCGGCTCCGCATCGGCGGCTGCCCAATAGATACC
84 Mutagenesis R90A/R91A/R92A TGCGGAGCCGCACGCCGCAGCCATCGTCACCACCG
85 CGGTGGTGACGATGGCTGCGGCGTGCGGCTCCGCA
86 Mutagenesis R92A CCGCACCGCCGTGCCATCGTCACCACC
87 GGTGGTGACGATGGCACGGCGGTGCGG
Table S3 Data collection and refinement statistics (molecular replacement)
One crystal for each structure. Values for the highest-resolution shell are shown in parentheses.
Parameter Value
Data collection
Space group P1
Cell dimensions
a, b, c (A˚) 66.81, 78.13, 92.77
α, β , γ (◦) 94.54, 104.71, 98.57
Resolution (A˚) 50–2.59 (2.75–2.59)
Rmeas 9.3 (31.4)
I/σ I 11.15 (3.61)
Completeness (%) 94.4 (90.1)
Redundancy 2.50 (2.30)
Refinement
Resolution (A˚) 2.59
Number of reflections 51516
Rwork/R free 0.19/0.24
Number of atoms
Protein 11149
Ligand 113
Water 273
B-factor 28.2
RMSD
Bond lengths (A˚) 0.015
Bond angles (◦) 1.833
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